The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, ...
We need a reliable pipeline with new antibacterial agents that are innovative, affordable, accessible to all those who need ...
Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...
Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma -- Licensed SYN-020 to Rasayana Therapeutics ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers ...
The South County Federation, a coalition of area homeowners associations and individual residents, sponsored a virtual May 11 presentation on the status of area rail transportation projects, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results